Ligand Pharma (LGND) PT Raised to $144 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts LGND Hot Sheet
Price: $291.77 -0.96%
Rating Summary:
15 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
15 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
H.C. Wainwright analyst Joseph Pantginis raised the price target on Ligand Pharma (NASDAQ: LGND) to $144.00 (from $135.00) while maintaining a Buy rating.
You May Also Be Interested In
- Leerink Starts Ligand Pharma (LGND) at Outperform
- E Ink Holdings Inc (8069:TT) PT Lowered to NT$200 at Macquarie
- Maxis Bhd (MAXIS:MK) (MAXSF) PT Raised to MYR3.82 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
